March 2 Quick Takes: Merck to help manufacture J&J COVID vaccine; plus EMA, Neurocrine, and FDA reviews for Merck, Avadel and argenx

At a White House press briefing Tuesday, President Joe Biden said Merck & Co. Inc. (NYSE:MRK), with aid from the Defense Production Act, will help manufacture COVID-19 Vaccine Janssen from Johnson & Johnson (NYSE:JNJ).

FDA authorized the one-shot COVID-19 vaccine on Saturday. J&J plans to deliver 100 million doses of the vaccine in the U.S. by the end of May...